跳至主要内容
临床试验/NCT02094105
NCT02094105已完成不适用

Effect of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: 10-year Follow up of a Community-based, Controlled Study Among High Risk Population in China

Chinese Academy of Medical Sciences1 个研究点 分布在 1 个国家目标入组 45,386 人开始时间: 1999年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
45,386
试验地点
1
主要终点
incidence and mortality of ESCC

研究概览

简要总结

Importance: There are no global screening recommendations for esophageal squamous cell carcinoma (ESCC). Endoscopic screening has been investigated in high incidence areas of China since 1970's. But up until now there no apparent evidence that would lead to a reduction in disease morbidity and mortality.

Objective: To evaluate whether endoscopic screening and early intervention program could reduce the incidence or mortality of ESCC.

Design: Community-based, controlled cohort study among 45 386 residents, Endoscopy screening was completed from November 1999 to May of 2000. Subjects in intervention group were examined once during intervention period. The study follow-up concluded in December 2009.

Setting: High risk area of ESCC in China

Participants:Cluster sampling from communities with high rates of esophageal cancer. A set of villages with was selected as the study intervention community. Age 40 to 69 years residents were selected as an eligible population. Another set of villages was select as the control population. Buffer villages were set up between intervention and control group.

Intervention: Endoscopy with Lugol's iodine staining and early treatment on precancerous lesions was undergone for the intervention group.

Main Outcome(s) and Measure(s): Incidence and mortality ESCC

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
40 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • local residents
  • Men and women aged 40 to 69 years
  • no contraindications for endoscopic examinations (e.g. history of reaction of iodine or lidocaine), and who were mentally and physically competent to provide written informed consent.
  • informed consent

排除标准

  • Not local residents
  • age younger than 40 yrs and older than 69 yrs
  • History of reaction of iodine or lidocaine
  • contraindications for endoscopic examinations

结局指标

主要结局

incidence and mortality of ESCC

时间窗: 10 years

次要结局

  • Cumulative incidence and mortality of total cancer, and gastric cardia cancer(10 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Youlin Qiao

Professor and Director of Department of Cancer Epidemiology

Chinese Academy of Medical Sciences

研究点 (1)

Loading locations...

相似试验